FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $386,100 | +42.9% | 117,000 | +23.5% | 0.00% | 0.0% |
| Q1 2023 | $270,095 | -70.5% | 94,770 | -24.7% | 0.00% | -66.7% |
| Q4 2022 | $916,814 | +78.0% | 125,936 | +97.7% | 0.00% | +50.0% |
| Q3 2022 | $515,000 | +270.5% | 63,687 | +125.2% | 0.00% | – |
| Q2 2022 | $139,000 | -83.2% | 28,284 | -19.0% | 0.00% | -100.0% |
| Q1 2022 | $825,000 | -18.6% | 34,900 | -39.1% | 0.00% | 0.0% |
| Q4 2021 | $1,014,000 | +164.1% | 57,300 | +321.3% | 0.00% | +100.0% |
| Q3 2021 | $384,000 | +64.1% | 13,600 | -31.7% | 0.00% | – |
| Q1 2021 | $234,000 | +0.4% | 19,900 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $233,000 | +50.3% | 19,900 | +2.1% | 0.00% | – |
| Q3 2020 | $155,000 | -56.6% | 19,500 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $357,000 | +53.2% | 19,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $233,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |